Total Payments
$5,578
2024 Payments
$1,422
Companies
34
Transactions
95
Medicare Patients
1,729
Medicare Billing
$251,534
Payment Breakdown by Category
Food & Beverage$5,218 (93.5%)
Education$360.56 (6.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,218 | 91 | 93.5% |
| Education | $360.56 | 4 | 6.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Incyte Corporation | $608.30 | 9 | $0 (2024) |
| EMD Serono, Inc. | $510.52 | 5 | $0 (2024) |
| PFIZER INC. | $418.68 | 9 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $385.92 | 5 | $0 (2024) |
| Seagen Inc. | $366.25 | 6 | $0 (2023) |
| Merck Sharp & Dohme Corporation | $356.50 | 9 | $0 (2019) |
| Celgene Corporation | $274.33 | 5 | $0 (2021) |
| Amgen Inc. | $218.76 | 3 | $0 (2022) |
| Kite Pharma, Inc. | $212.99 | 2 | $0 (2019) |
| Pharmacosmos Therapeutics Inc. | $208.17 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,422 | 18 | PFIZER INC. ($272.26) |
| 2023 | $821.36 | 11 | EMD Serono, Inc. ($225.25) |
| 2022 | $946.19 | 16 | Seagen Inc. ($217.34) |
| 2021 | $432.40 | 7 | Incyte Corporation ($196.84) |
| 2020 | $16.61 | 1 | Janssen Biotech, Inc. ($16.61) |
| 2019 | $765.58 | 19 | Merck Sharp & Dohme Corporation ($240.63) |
| 2018 | $905.27 | 14 | Astellas Pharma US Inc ($194.99) |
| 2017 | $268.74 | 9 | PFIZER INC. ($133.23) |
All Payment Transactions
95 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/07/2024 | Incyte Corporation | MONJUVI (Drug) | Food and Beverage | Cash or cash equivalent | $70.44 | General |
| Category: Oncology | ||||||
| 10/08/2024 | Incyte Corporation | — | Education | Cash or cash equivalent | $49.99 | General |
| 09/10/2024 | ABBVIE INC. | VENCLEXTA (Drug) | Food and Beverage | In-kind items and services | $97.47 | General |
| Category: ONCOLOGY | ||||||
| 08/16/2024 | Bayer Healthcare Pharmaceuticals Inc. | Xofigo (Drug) | Food and Beverage | In-kind items and services | $118.30 | General |
| Category: Oncology | ||||||
| 06/19/2024 | Incyte Corporation | PEMAZYRE (Drug) | Food and Beverage | Cash or cash equivalent | $123.20 | General |
| Category: Hepatology (Liver, Pancreatic, Gall Bladder) | ||||||
| 05/15/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $70.31 | General |
| 05/15/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $17.45 | General |
| Category: Cardiovascular | ||||||
| 05/13/2024 | PFIZER INC. | BOSULIF (Drug), ELREXFIO, ADCETRIS | Food and Beverage | In-kind items and services | $14.37 | General |
| Category: METABOLIC DISEASE;ONCOLOGY | ||||||
| 05/09/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $124.55 | General |
| Category: ONCOLOGY | ||||||
| 04/24/2024 | BeiGene USA, Inc. | BRUKINSA (Drug) | Food and Beverage | In-kind items and services | $91.31 | General |
| Category: Oncology | ||||||
| 04/18/2024 | Tempus AI, Inc | — | Food and Beverage | In-kind items and services | $28.37 | General |
| 04/09/2024 | PFIZER INC. | PADCEV (Biological) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Oncology | ||||||
| 04/05/2024 | PFIZER INC. | IBRANCE (Drug), TUKYSA | Food and Beverage | In-kind items and services | $0.53 | General |
| Category: ONCOLOGY | ||||||
| 04/02/2024 | PFIZER INC. | IBRANCE (Drug), TUKYSA | Food and Beverage | In-kind items and services | $7.38 | General |
| Category: ONCOLOGY | ||||||
| 03/26/2024 | PFIZER INC. | TUKYSA (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Oncology | ||||||
| 03/14/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $118.00 | General |
| 02/29/2024 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Food and Beverage | In-kind items and services | $119.45 | General |
| Category: Oncology | ||||||
| 01/25/2024 | Pharmacosmos Therapeutics Inc. | MONOFERRIC (Drug) | Food and Beverage | In-kind items and services | $120.83 | General |
| Category: HEMATOLOGY | ||||||
| 12/13/2023 | Rigel Pharmaceuticals, Inc. | Rezlidhia (Drug), Tavalisse | Food and Beverage | Cash or cash equivalent | $76.76 | General |
| Category: Acute Myeloid Leukemia | ||||||
| 12/07/2023 | Seagen Inc. | TUKYSA (Drug) | Food and Beverage | In-kind items and services | $121.41 | General |
| Category: Oncology | ||||||
| 10/12/2023 | GENZYME CORPORATION | SARCLISA (Biological) | Food and Beverage | In-kind items and services | $48.33 | General |
| Category: Oncology | ||||||
| 10/10/2023 | ADC Therapeutics America, Inc. | — | Food and Beverage | In-kind items and services | $14.15 | General |
| 09/27/2023 | EMD Serono, Inc. | BAVENCIO (Drug) | Food and Beverage | Cash or cash equivalent | $124.55 | General |
| Category: Oncology | ||||||
| 08/16/2023 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Food and Beverage | In-kind items and services | $69.35 | General |
| Category: Oncology | ||||||
| 06/21/2023 | Pharmacyclics LLC, An AbbVie Company | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $19.81 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 571 | 1,023 | $182,976 | $83,251 |
| 2022 | 10 | 536 | 1,126 | $196,654 | $87,809 |
| 2021 | 10 | 484 | 885 | $137,037 | $66,376 |
| 2020 | 5 | 138 | 213 | $31,773 | $14,097 |
Total Patients
1,729
Total Services
3,247
Medicare Billing
$251,534
Procedure Codes
37
All Medicare Procedures & Services
37 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 153 | 328 | $54,120 | $21,902 | 40.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 40 | 124 | $27,404 | $13,512 | 49.3% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 46 | 127 | $20,320 | $11,659 | 57.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 83 | 113 | $18,655 | $8,584 | 46.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 62 | 114 | $13,110 | $6,799 | 51.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 45 | 51 | $16,473 | $6,701 | 40.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 51 | 59 | $13,157 | $5,771 | 43.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 17 | 29 | $6,433 | $3,265 | 50.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 34 | 37 | $4,440 | $1,507 | 33.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 11 | 11 | $3,509 | $1,403 | 40.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 13 | 13 | $3,315 | $1,273 | 38.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 16 | 17 | $2,040 | $876.01 | 42.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 171 | 573 | $94,441 | $40,608 | 43.0% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 61 | 174 | $27,840 | $13,809 | 49.6% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 53 | 60 | $19,344 | $9,223 | 47.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 87 | 111 | $14,082 | $5,208 | 37.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 56 | 88 | $10,120 | $4,895 | 48.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 23 | 30 | $6,630 | $3,409 | 51.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 22 | 22 | $7,018 | $3,224 | 45.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 29 | 29 | $7,369 | $2,792 | 37.9% |
| 99220 | Initial hospital observation care per day, typically 70 minutes | Facility | 2022 | 12 | 17 | $4,930 | $2,390 | 48.5% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 22 | 22 | $4,880 | $2,250 | 46.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 142 | 339 | $53,223 | $25,714 | 48.3% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 42 | 103 | $16,480 | $8,369 | 50.8% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 26 | 71 | $14,910 | $8,338 | 55.9% |
About Eric Kirby
Eric Kirby is a Internal Medicine healthcare provider based in Middleburg Heights, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/09/2014. The National Provider Identifier (NPI) number assigned to this provider is 1811316565.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Eric Kirby has received a total of $5,578 in payments from pharmaceutical and medical device companies, with $1,422 received in 2024. These payments were reported across 95 transactions from 34 companies. The most common payment nature is "Food and Beverage" ($5,218).
As a Medicare-enrolled provider, Kirby has provided services to 1,729 Medicare beneficiaries, totaling 3,247 services with total Medicare billing of $251,534. Data is available for 4 years (2020–2023), covering 37 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Middleburg Heights, OH
- Active Since 04/09/2014
- Last Updated 01/19/2021
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1811316565
Products in Payments
- TUKYSA (Drug) $468.32
- KEYTRUDA (Biological) $356.50
- JAKAFI (Drug) $241.50
- BAVENCIO (Drug) $225.25
- Yescarta (Drug) $212.99
- MONOFERRIC (Drug) $208.17
- MONJUVI (Drug) $177.53
- OPDIVO (Biological) $174.04
- TAGRISSO (Drug) $169.78
- IMBRUVICA (Drug) $154.25
- ELIQUIS (Drug) $147.81
- Blincyto (Biological) $134.63
- CALQUENCE (Drug) $131.44
- PADCEV (Biological) $124.99
- XARELTO (Drug) $124.99
- LIBTAYO (Biological) $124.55
- PEMAZYRE (Drug) $123.20
- JEVTANA (Drug) $121.78
- Xofigo (Drug) $118.30
- VENCLEXTA (Drug) $97.47
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Middleburg Heights
Newton Muthunayagam, M.d, M.D
Internal Medicine — Payments: $61,649
Internal Medicine $61,649
Dr. Sanjay Choudhary, Md, MD
Internal Medicine — Payments: $14,227
Internal Medicine $14,227
Brendan Kappus, Do, DO
Internal Medicine — Payments: $12,340
Internal Medicine $12,340
Trilok Sharma, Md, MD
Internal Medicine — Payments: $3,905
Internal Medicine $3,905
Linda Dilisi, Md, MD
Internal Medicine — Payments: $1,655
Internal Medicine $1,655
Dr. Mohammad Karim, Md, MD
Internal Medicine — Payments: $540.93
Internal Medicine $540.93